
Nita M. Minnifield
Examiner (ID: 7424, Phone: (571)272-0860 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1802, 1621, 1817, 1813, 1645 |
| Total Applications | 1564 |
| Issued Applications | 1017 |
| Pending Applications | 126 |
| Abandoned Applications | 425 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11191760
[patent_doc_number] => 09422564
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-23
[patent_title] => 'Immunostimulatory sequence oligonucleotides and methods of using the same'
[patent_app_type] => utility
[patent_app_number] => 14/518933
[patent_app_country] => US
[patent_app_date] => 2014-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 44622
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14518933
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/518933 | Immunostimulatory sequence oligonucleotides and methods of using the same | Oct 19, 2014 | Issued |
Array
(
[id] => 11047553
[patent_doc_number] => 20160244511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'CROSS-REACTIVE STAPHYLOCOCCUS AUREUS ANTIBODY SEQUENCES'
[patent_app_type] => utility
[patent_app_number] => 15/029944
[patent_app_country] => US
[patent_app_date] => 2014-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 33942
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15029944
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/029944 | CROSS-REACTIVE STAPHYLOCOCCUS AUREUS ANTIBODY SEQUENCES | Oct 16, 2014 | Abandoned |
Array
(
[id] => 10213959
[patent_doc_number] => 20150098951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-09
[patent_title] => 'MODULATORS OF CANDIDA HYPHAL MORPHOGENESIS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/517545
[patent_app_country] => US
[patent_app_date] => 2014-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11443
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14517545
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/517545 | MODULATORS OF CANDIDA HYPHAL MORPHOGENESIS AND USES THEREOF | Oct 16, 2014 | Abandoned |
Array
(
[id] => 10213970
[patent_doc_number] => 20150098962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-09
[patent_title] => 'MODULATORS OF CANDIDA HYPHAL MORPHOGENESIS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/517528
[patent_app_country] => US
[patent_app_date] => 2014-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11442
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14517528
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/517528 | MODULATORS OF CANDIDA HYPHAL MORPHOGENESIS AND USES THEREOF | Oct 16, 2014 | Abandoned |
Array
(
[id] => 11040171
[patent_doc_number] => 20160237127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-18
[patent_title] => 'RECOMBINANT PEPTIDE VACCINES AGAINST TICKS, AND NUCLEOTIDE SEQUENCES CODING FOR THE RECOMBINANT PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 15/029982
[patent_app_country] => US
[patent_app_date] => 2014-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8014
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15029982
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/029982 | Recombinant peptide vaccines against ticks, and nucleotide sequences coding for the recombinant peptides | Oct 14, 2014 | Issued |
Array
(
[id] => 14759573
[patent_doc_number] => 10391167
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-27
[patent_title] => Mucosal vaccine composition
[patent_app_type] => utility
[patent_app_number] => 14/917077
[patent_app_country] => US
[patent_app_date] => 2014-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 26
[patent_no_of_words] => 10980
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14917077
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/917077 | Mucosal vaccine composition | Oct 1, 2014 | Issued |
Array
(
[id] => 11046274
[patent_doc_number] => 20160243232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'PROSTATE CANCER TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 15/025911
[patent_app_country] => US
[patent_app_date] => 2014-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6918
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15025911
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/025911 | PROSTATE CANCER TREATMENT | Sep 28, 2014 | Abandoned |
Array
(
[id] => 11047530
[patent_doc_number] => 20160244488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'CHOLERA TOXIN A-LIKE POLYPEPTIDE USEFUL AS ADJUVANT COMPONENT'
[patent_app_type] => utility
[patent_app_number] => 15/023664
[patent_app_country] => US
[patent_app_date] => 2014-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12737
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15023664
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/023664 | CHOLERA TOXIN A-LIKE POLYPEPTIDE USEFUL AS ADJUVANT COMPONENT | Sep 22, 2014 | Abandoned |
Array
(
[id] => 9930904
[patent_doc_number] => 20150079095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-19
[patent_title] => 'PREVENTON, TREATMENT AND DIAGNOSIS OF P. GINGIVALIS INFECTION'
[patent_app_type] => utility
[patent_app_number] => 14/487461
[patent_app_country] => US
[patent_app_date] => 2014-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16898
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14487461
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/487461 | Prevention, treatment and diagnosis of P. gingivalis infection | Sep 15, 2014 | Issued |
Array
(
[id] => 9930922
[patent_doc_number] => 20150079115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-19
[patent_title] => 'Compositions and Methods for Preventing or Relieving Symptoms of Infections'
[patent_app_type] => utility
[patent_app_number] => 14/487592
[patent_app_country] => US
[patent_app_date] => 2014-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6276
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14487592
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/487592 | Compositions and methods for preventing or relieving symptoms of infections | Sep 15, 2014 | Issued |
Array
(
[id] => 10219838
[patent_doc_number] => 20150104832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-16
[patent_title] => 'METHOD FOR MODULATING GENE EXPRESSION BY MODIFYING THE CPG CONTENT'
[patent_app_type] => utility
[patent_app_number] => 14/483142
[patent_app_country] => US
[patent_app_date] => 2014-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12733
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14483142
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/483142 | Method for modulating gene expression by modifying the CpG content | Sep 9, 2014 | Issued |
Array
(
[id] => 11520542
[patent_doc_number] => 09603923
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-28
[patent_title] => 'Universal carrier for targeting molecules to GB3 receptor expressing cells'
[patent_app_type] => utility
[patent_app_number] => 14/478687
[patent_app_country] => US
[patent_app_date] => 2014-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 6107
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14478687
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/478687 | Universal carrier for targeting molecules to GB3 receptor expressing cells | Sep 4, 2014 | Issued |
Array
(
[id] => 12044559
[patent_doc_number] => 09822150
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-21
[patent_title] => 'Neisseria meningitidis compositions and methods thereof'
[patent_app_type] => utility
[patent_app_number] => 14/470922
[patent_app_country] => US
[patent_app_date] => 2014-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 27343
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14470922
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/470922 | Neisseria meningitidis compositions and methods thereof | Aug 26, 2014 | Issued |
Array
(
[id] => 11016765
[patent_doc_number] => 20160213718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-28
[patent_title] => 'A Probiotic Composition Comprising The Novel Isolated Bacterial Strain of Brevibacterium casei AP9'
[patent_app_type] => utility
[patent_app_number] => 14/913497
[patent_app_country] => US
[patent_app_date] => 2014-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7244
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14913497
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/913497 | Probiotic composition comprising the novel isolated bacterial strain of brevibacterium casei AP9 | Aug 21, 2014 | Issued |
Array
(
[id] => 10953374
[patent_doc_number] => 20140356395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-04
[patent_title] => 'METHODS AND MATERIALS FOR PRODUCING IMMUNE RESPONSES AGAINST POLYPEPTIDES INVOLVED IN ANTIBIOTIC RESISTANCE'
[patent_app_type] => utility
[patent_app_number] => 14/462099
[patent_app_country] => US
[patent_app_date] => 2014-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3741
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14462099
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/462099 | METHODS AND MATERIALS FOR PRODUCING IMMUNE RESPONSES AGAINST POLYPEPTIDES INVOLVED IN ANTIBIOTIC RESISTANCE | Aug 17, 2014 | Abandoned |
Array
(
[id] => 10996382
[patent_doc_number] => 20160193328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-07
[patent_title] => 'Immunoadjuvant Compositions and uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/911944
[patent_app_country] => US
[patent_app_date] => 2014-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13128
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14911944
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/911944 | Immunoadjuvant Compositions and uses Thereof | Aug 13, 2014 | Abandoned |
Array
(
[id] => 11244645
[patent_doc_number] => 09470684
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-18
[patent_title] => 'Outer membrane protein 18 as a diagnostic marker for campylobacter'
[patent_app_type] => utility
[patent_app_number] => 14/451843
[patent_app_country] => US
[patent_app_date] => 2014-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 3690
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14451843
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/451843 | Outer membrane protein 18 as a diagnostic marker for campylobacter | Aug 4, 2014 | Issued |
Array
(
[id] => 9864680
[patent_doc_number] => 20150044698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-12
[patent_title] => 'OUTER MEMBRANE PROTEIN 18 AS A DIAGNOSTIC MARKER FOR CAMPYLOBACTER'
[patent_app_type] => utility
[patent_app_number] => 14/451847
[patent_app_country] => US
[patent_app_date] => 2014-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3697
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14451847
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/451847 | OUTER MEMBRANE PROTEIN 18 AS A DIAGNOSTIC MARKER FOR CAMPYLOBACTER | Aug 4, 2014 | Abandoned |
Array
(
[id] => 10960436
[patent_doc_number] => 20140363462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-11
[patent_title] => 'HETEROLOGOUS EXPRESSION OF NEISSERIAL PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 14/448792
[patent_app_country] => US
[patent_app_date] => 2014-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 36108
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14448792
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/448792 | Heterologous expression of Neisserial proteins | Jul 30, 2014 | Issued |
Array
(
[id] => 10621648
[patent_doc_number] => 09340586
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-17
[patent_title] => 'Streptococcus pyogenes antigens and corresponding DNA fragments'
[patent_app_type] => utility
[patent_app_number] => 14/448719
[patent_app_country] => US
[patent_app_date] => 2014-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 20
[patent_no_of_words] => 11473
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14448719
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/448719 | Streptococcus pyogenes antigens and corresponding DNA fragments | Jul 30, 2014 | Issued |